DE134234C - - Google Patents
Info
- Publication number
- DE134234C DE134234C DENDAT134234D DE134234DA DE134234C DE 134234 C DE134234 C DE 134234C DE NDAT134234 D DENDAT134234 D DE NDAT134234D DE 134234D A DE134234D A DE 134234DA DE 134234 C DE134234 C DE 134234C
- Authority
- DE
- Germany
- Prior art keywords
- acid
- salicylid
- chloroform
- water
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- YGSDEFSMJLZEOE-UHFFFAOYSA-N Salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims description 24
- 239000002253 acid Substances 0.000 claims description 17
- 229960004889 salicylic acid Drugs 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 5
- XHXFXVLFKHQFAL-UHFFFAOYSA-N Phosphoryl chloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 claims description 4
- 238000009835 boiling Methods 0.000 claims description 4
- RBTARNINKXHZNM-UHFFFAOYSA-K Iron(III) chloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 claims description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims 21
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims 9
- 238000006243 chemical reaction Methods 0.000 claims 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims 4
- 238000002844 melting Methods 0.000 claims 3
- 229960000583 Acetic Acid Drugs 0.000 claims 2
- 239000007795 chemical reaction product Substances 0.000 claims 2
- 239000012362 glacial acetic acid Substances 0.000 claims 2
- 239000000843 powder Substances 0.000 claims 2
- 239000000047 product Substances 0.000 claims 2
- ZXACBHMKACDPEG-UHFFFAOYSA-M 2-hydroxybenzoic acid;chloride Chemical compound [Cl-].OC(=O)C1=CC=CC=C1O ZXACBHMKACDPEG-UHFFFAOYSA-M 0.000 claims 1
- YCPXWRQRBFJBPZ-UHFFFAOYSA-N 5-Sulfosalicylic acid Chemical compound OC(=O)C1=CC(S(O)(=O)=O)=CC=C1O YCPXWRQRBFJBPZ-UHFFFAOYSA-N 0.000 claims 1
- 150000007513 acids Chemical class 0.000 claims 1
- 239000003513 alkali Substances 0.000 claims 1
- 238000004458 analytical method Methods 0.000 claims 1
- 239000003518 caustics Substances 0.000 claims 1
- 238000001816 cooling Methods 0.000 claims 1
- 238000000354 decomposition reaction Methods 0.000 claims 1
- 238000001704 evaporation Methods 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 239000000155 melt Substances 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 238000006396 nitration reaction Methods 0.000 claims 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 230000002035 prolonged Effects 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
- 239000000523 sample Substances 0.000 claims 1
- 230000014860 sensory perception of taste Effects 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 239000007858 starting material Substances 0.000 claims 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims 1
- 230000035917 taste Effects 0.000 claims 1
- 235000019640 taste Nutrition 0.000 claims 1
- WFDIJRYMOXRFFG-UHFFFAOYSA-N acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 4
- 150000008064 anhydrides Chemical class 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- WLPQCHKXJRHZRI-UHFFFAOYSA-N (2-hydroxybenzoyl) 2-hydroxybenzoate Chemical compound OC1=CC=CC=C1C(=O)OC(=O)C1=CC=CC=C1O WLPQCHKXJRHZRI-UHFFFAOYSA-N 0.000 description 2
- 210000002784 Stomach Anatomy 0.000 description 2
- 229960001138 acetylsalicylic acid Drugs 0.000 description 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N Catechol Chemical group OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Natural products OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 229940058287 Salicylic acid derivative anticestodals Drugs 0.000 description 1
- JNELGWHKGNBSMD-UHFFFAOYSA-N Xanthone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3OC2=C1 JNELGWHKGNBSMD-UHFFFAOYSA-N 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 230000002378 acidificating Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000000875 corresponding Effects 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000000968 intestinal Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 150000003873 salicylate salts Chemical class 0.000 description 1
- 231100000486 side effect Toxicity 0.000 description 1
- 230000001225 therapeutic Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
KAISERLICHESIMPERIAL
PATENTAMT.PATENT OFFICE.
M 134234 KLASSE 12 (j. M 134234 CLASS 12 (j.
Das Studium der Anhydride der Salicylsäure hat bereits verschiedene Forscher beschäftigt. Kraut erhielt (Ann. d. Chemie, Bd. 74 [neue Reihe], S. 13) durch Erhitzen von Acctylchlorid mit Salicylsäure auf 130 bis 140° ein hellgelbes, zu einer harzartigen Masse erstarrendes OeI, welches er für identisch hält mit dem durch Erhitzen von Acetylsalicylsäure auf 140 bis 1700 unter Austritt von Acetanhydrid gebildeten Körper. Kraut.hält diese Verbindung, die er offenbar in reinem Zustande nicht in Händen gehabt hat, nicht für ein Sa'üreanhydrid, sondern für eine der Äcetosalicylsäure entsprechende Salicylosalicylsäure. Thatsä.chlich zeigt der nach Kraut's Angaben hergestellte Körper, in Weingeist gelösf und mit Wasser verdünnt, noch saure Eigenschaften. Von seiner Salicylosalicylsäure bezw. auch direct von der Acetylsalicylsäure gelangte Kraut zu seiner Trisalicylosalicylsäure, wenn er die Temperatur auf 2oo° steigerte, wobei die Anhydridbildung sich zwischen mehreren Molecülen vollzog, aber augenscheinlich so, dafs im Endkörper noch immer eine Hydroxyl-(Phenol-)Gruppe und somit auch eine Carboxylgruppe intact geblieben waren. Kraut's Trisalicylosalicylsäure ist sehr leicht löslich in Alkohol und Aether. Schiff (Ann. 87 [neue Reihe] S. 218), der darauf hinweist, dafs Salicylsäureanhydrid mit Eisenchlorid keine Färbung giebt, will das Anhydrid durch Erwärmen von Salicylsäure mit Phosphoroxychlorid erhalten haben, doch giebt er an, dafs hierbei ein in kochendem Alkohol löslicher und ein darin unlöslicher Körper entstehen; ersleren hält er für Salicylid, letzteren für Tetrasalicylid. Schiff bezweifelt auch, dafs Kraut reine Verbindungen unter Händen gehabt habe, womit auch die Versuche des Erfinders in Einklang stehen. Weiter,hat H. W. Perkin (Berichte 1883, S. 339) versucht, das Anhydrid der Salicylsäure darzustellen, indem er Salicylsäure mit Essigsäure anhydrid erhitzte. Als Zwischenproduct erhielt er eitle zähe Masse, von der er annimmt, dafs sie zum grofsen Theil aus Salicylid besteht; dieselbe liefert bei der Destillation in allerdings schlechter Ausbeute Xanthon. Salicylid · zu isoliren hat Perkin nicht versucht.The study of the anhydrides of salicylic acid has already occupied various researchers. Kraut received (Ann. D. Chemie, Vol. 74 [new series], p. 13) by heating acctyl chloride with salicylic acid to 130 to 140 ° a light yellow oil that solidifies to a resinous mass, which he considers to be identical to the through Heating of acetylsalicylic acid to 140 to 170 0 with the escape of acetic anhydride. Kraut. Considers this compound, which he evidently did not have in his hands in the pure state, not to be an acid anhydride, but rather a salicylosalicylic acid corresponding to acetosalicylic acid. In fact, the body produced according to Kraut's information, dissolved in alcohol and diluted with water, still shows acidic properties. From his salicylosalicylic acid respectively. Kraut also got its trisalicylosalicylic acid directly from acetylsalicylic acid when he raised the temperature to 200 °, the anhydride formation taking place between several molecules, but evidently so that there was still a hydroxyl (phenol) group in the end body and thus also one Carboxyl group remained intact. Kraut's trisalicylosalicylic acid is very easily soluble in alcohol and ether. Schiff (Ann. 87 [new series], p. 218), who points out that salicylic anhydride does not give any coloration with ferric chloride, claims to have obtained the anhydride by heating salicylic acid with phosphorus oxychloride, but he states that it is more soluble in boiling alcohol and a body insoluble in it arise; The former he considers salicylid, the latter tetrasalicylid. Schiff also doubts that Kraut had pure compounds in its hands, with which the inventor's experiments are also in accord. Furthermore, HW Perkin (reports 1883, p. 339) tried to represent the anhydride of salicylic acid by heating salicylic acid with acetic anhydride. As an intermediate product he received a vain, viscous mass, which he assumes to consist for the most part of salicylide; the same gives xanthone in the distillation, however, in poor yield. Perkin did not attempt to isolate salicylide.
Die vorstehend angeführten und sonst noch vorhandenen Literaturangaben enthalten wohl Muthmafsungen und Widersprüche bezüglich der Constitution der Salicylsäureanhydride, geben aber kein Verfahren zur glatten Darstellung eines von Salicylsäure und sonstigen Verunreinigungen freien Salicylids. Für die Therapeutik hat aber ein derartiges Verfahren ein wesentliches Interesse, denn seit der Einführung der Salicylsäure in den Arzneischatz ist man bestrebt, ein Salicylsäuredcrivat darzustellen, das den Magen nicht belästigt, frei von unangenehmen Nebenwirkungen ist und erst in Berührung mit der Darmwand Salicylsäure regenerirt. Die Salicylate werden durchweg bereits im Magen gespalten und auch die Acetsalicylsäure erleidet bereits durch verdünnte Säure Spaltung. Am meisten resistent sind von den bislang für medicinische Anwendung vorgeschlagenen Salicylsäurederivaten noch die Salicylphenolester oder Salole, doch kommt denselben neben der Salicylwirkung noch die oft unangenehm empfundene specitische Wirkung der Phenole zu. Von diesen Nachlheilen frei ist das Salicylid.The literature references cited above and otherwise available probably contain There are assumptions and contradictions regarding the constitution of salicylic anhydrides but not a method of smoothly displaying any of salicylic acid and other impurities free salicylids. For therapeutics, however, such a method has an essential interest, because since its introduction of the salicylic acid in the medicinal treasure, efforts are made to represent a salicylic acid derivative, that does not bother the stomach, is free from unpleasant side effects and only in Contact with the intestinal wall regenerates salicylic acid. The salicylates are consistently already split in the stomach and the acetalicylic acid also suffers from being diluted Acid cleavage. The most resistant are those for medicinal use up to now proposed salicylic acid derivatives nor the salicylphenol esters or salols, but comes in addition to the salicylic effect, there is also the specitic effect, which is often perceived as unpleasant of phenols too. Salicylid is free from these after-healing effects.
Es wurde nun gefunden, dafs die Acetsalicylsäure bereits beim Erhitzen auf 150 bis i6o° , sehr allmählich unter Essigsäureabspaltung Sa-It has now been found that the acetalicylic acid already on heating to 150 to 160 ° , very gradually with elimination of acetic acid
Claims (1)
Verfahren zur Herstellung von Salicylid, darin bestehend, dafs man Acetsalicylsäure 5 bis 6 Stunden lang auf 200 bis 210° erhitzt, das Reactionsproduct mit Wasser auskocht, es sodann in Aceton oder ähnlich wirkenden Lösungsmitteln löst und mit Wasser fallt.Patent-A ν SPR υ cn:
Process for the preparation of salicylid, consisting in that acetalicylic acid is heated for 5 to 6 hours at 200 to 210 °, the reaction product is boiled with water, it is then dissolved in acetone or similar solvents and precipitated with water.
Publications (1)
Publication Number | Publication Date |
---|---|
DE134234C true DE134234C (en) |
Family
ID=402375
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DENDAT134234D Active DE134234C (en) |
Country Status (1)
Country | Link |
---|---|
DE (1) | DE134234C (en) |
-
0
- DE DENDAT134234D patent/DE134234C/de active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE134234C (en) | ||
DE414190C (en) | Process for the preparation of citric acid tribenzyl ester | |
DE537106C (en) | Process for the preparation of o, o -diphenylphenolphthalein and o, o-dioxydiphenolphthalein and their acetyl derivatives | |
DE81068C (en) | ||
DE211403C (en) | ||
DE541316C (en) | Process for the preparation of esters or ethers of halogenated carvacroles | |
DE229143C (en) | ||
AT42151B (en) | Process for the preparation of mild laxatives from phenolphthalein. | |
AT52968B (en) | Process for the preparation of water-soluble, crystalline aluminum formates. | |
AT157720B (en) | Process for the production of glucosides. | |
DE762123C (en) | Process for the production of physiologically active compounds of 2-alkyl-1,4-naphthoquinone or hydroquinone | |
DE386743C (en) | Process for the preparation of N-alkylamino fatty acids and their N-acidyl derivatives | |
DE629054C (en) | Process for the production of pellets of tertiary aliphatic amino acids | |
DE227013C (en) | ||
DE545913C (en) | Process for the preparation of i-eugenol | |
DE247817C (en) | ||
AT117475B (en) | Process for the preparation of substitution products of ß-iodopyridine. | |
DE357753C (en) | Process for the preparation of a quinine derivative | |
DE424613C (en) | Process for the purification of thionyl-p-azo-o-aminotoluene | |
AT149992B (en) | Process for the preparation of 2-keto-l-gulonic acid. | |
AT126375B (en) | Process for the preparation of compounds with hydrogenated ring systems. | |
AT69849B (en) | Process for the preparation of esters of oxyquinolines. | |
DE702185C (en) | hen calcium double salts of ascorbic acid | |
DE682077C (en) | Process for the preparation of oxyaryl alkyl ketones | |
DE1593744A1 (en) | New hydroxybenzoic acid derivatives and processes for their preparation |